Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133531 | 12613353 | 1 | I | 20160726 | 20160802 | 20160802 | EXP | US-AMGEN-USASP2016097570 | AMGEN | 0.00 | F | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133531 | 12613353 | 1 | PS | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | UNK | U | 103234 | UNKNOWN FORMULATION | ||||||||
| 126133531 | 12613353 | 2 | SS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | UNK | U | 0 | SOLUTION FOR INJECTION | ||||||||
| 126133531 | 12613353 | 3 | SS | ARANESP | DARBEPOETIN ALFA | 1 | U | 0 | SOLUTION FOR INJECTION | ||||||||||
| 126133531 | 12613353 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, (3 CAPSULES BY MOUTH AT BEDTIME AS DIRECTED) | 0 | 75 | MG | CAPSULE | |||||||
| 126133531 | 12613353 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 55 MCG, (THYROID) 1 DAY | 0 | 55 | UG | |||||||||
| 126133531 | 12613353 | 6 | C | TORSEMIDE. | TORSEMIDE | 1 | 20 MG, QOD (DIURETIC) 2 EVERY 2 DAYS | 0 | 20 | MG | QD | ||||||||
| 126133531 | 12613353 | 7 | C | FISH OIL | FISH OIL | 1 | 300 MG, UNK | 0 | 300 | MG | CAPSULE | ||||||||
| 126133531 | 12613353 | 8 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | UNK UNK, QD (2 DAILY) | 0 | QD | ||||||||||
| 126133531 | 12613353 | 9 | C | URSODIOL. | URSODIOL | 1 | 300 MG, UNK (LIVER) 3 DAY | 0 | 300 | MG | |||||||||
| 126133531 | 12613353 | 10 | C | LACTULOSE. | LACTULOSE | 1 | 10 CM/15ML SOLUTION 3 30ML TWICE DAY | 0 | BID | ||||||||||
| 126133531 | 12613353 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | SOD DR MG 1 DAILY | 0 | QD | ||||||||||
| 126133531 | 12613353 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK UNK, MTHLY | 0 | INJECTION | /month | |||||||||
| 126133531 | 12613353 | 13 | C | FENTANYL. | FENTANYL | 1 | 50 MCG/HR PATCH CHANGE EVERY OTHER DAY | 0 | 50 | UG | /hr | ||||||||
| 126133531 | 12613353 | 14 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | 4 MG, UNK (3 DAYS) | 0 | 4 | MG | |||||||||
| 126133531 | 12613353 | 15 | C | KEFLEX | CEPHALEXIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 126133531 | 12613353 | 16 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | UNK (3 DAYS) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126133531 | 12613353 | 1 | Bone marrow myelogram abnormal |
| 126133531 | 12613353 | 2 | Renal failure |
| 126133531 | 12613353 | 3 | Nephrogenic anaemia |
| 126133531 | 12613353 | 4 | Product used for unknown indication |
| 126133531 | 12613353 | 16 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126133531 | 12613353 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126133531 | 12613353 | Ammonia abnormal | |
| 126133531 | 12613353 | Bladder disorder | |
| 126133531 | 12613353 | Breakthrough pain | |
| 126133531 | 12613353 | Drug ineffective | |
| 126133531 | 12613353 | Hot flush | |
| 126133531 | 12613353 | Muscle twitching | |
| 126133531 | 12613353 | Nerve injury | |
| 126133531 | 12613353 | Precancerous skin lesion | |
| 126133531 | 12613353 | Sleep apnoea syndrome | |
| 126133531 | 12613353 | Surgery |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126133531 | 12613353 | 1 | 2011 | 0 | ||
| 126133531 | 12613353 | 2 | 2011 | 0 |